Maribao, Kim Estila L.

HRN: 25-79-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2025
CEFTAZIDIME 1GM (VIAL)
12/18/2025
12/24/2025
IVT
750mg
Q8
Sepsis
Checking Final Appropriateness 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines